Work

Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate

Year: 2021

Type: article

Abstract: The COVID-19 pandemic affected transplant center activity in areas with high number of cases such as New York City and prompted reevaluation of patients awaiting organ transplant diagnosed with SARS-CoV-2 infection. To resume safe transplantation at our center, we found it necessary to (1) identify transplant candidates with possible exposure to or history of COVID-19 infection, (2) outline a clinical and laboratory assessment to determine adequate clinical recovery from COVID-19 for transplantation, and (3) determine whether the possibility of perioperative COVID-19 transmission from the patient to staff would pose unacceptable risk. Here, we describe our center's approach to proceeding with transplantation in a SARS-CoV-2 seropositive living donor kidney transplant recipient and describe early posttransplant outcomes.

Source: Case Reports in Nephrology

DOI: 10.1155/2021/6613023

Authors: Maya C. Graves, Sapna A. Mehta, Bonnie E. Lonze, Nicole M. Ali

Institutions: New York University, NYU Langone Health

Language: English

Topic: Organ Donation and Transplantation

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $790